Related references
Note: Only part of the references are listed.Propranolol for Off-label Treatment of Patients With Melanoma Results From a Cohort Study
Vincenzo De Giorgi et al.
JAMA ONCOLOGY (2018)
Tetrodotoxin-insensitive electrical field stimulation-induced contractions on Crotalus durissus terrificus corpus cavernosum
Rafael Campos et al.
PLOS ONE (2017)
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment
Eddy Pasquier et al.
Oncotarget (2015)
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
H. M. Wang et al.
ANNALS OF ONCOLOGY (2013)
Endothelial Cells Are Able to Synthesize and Release Catecholamines Both In Vitro and In Vivo
Daniela Sorriento et al.
HYPERTENSION (2012)
β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
Stanley Lemeshow et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Beta Blockers and Breast Cancer Mortality: A Population-Based Study
Thomas I. Barron et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
Amal Melhem-Bertrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Share Paper
